Cediranib monotherapy in patients with advanced renal cell carcinoma: Results of a randomised phase II study

Author(s):
Mulders, P.; Hawkins, R.; Nathan, P.; Jong, I. de; Osanto, S.; Porfiri, E.; Protheroe, A.; Herpen, C.M.L. van; Mookerjee, B.; Pike, L.; Jurgensmeier, J.M.; Gore, M.E.
Published
2012
Publication type
Article / Letter to editor
CediranibMonotherapyRenal cell carcinomaPhase II
Date issued
2012-03-31
Language
English
Is part of
European Journal of Cancer (2012), Vol. 48, no. 4, p. 527-537
hdl
1887/100443
doi
10.1016/j.ejca.2011.12.022